vs
Orthofix Medical Inc.（OFIX）与Wheels Up Experience Inc.（UP）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Wheels Up Experience Inc.的1.2倍（$219.9M vs $183.8M），Orthofix Medical Inc.净利率更高（-1.0% vs -15.7%，领先14.7%），Orthofix Medical Inc.同比增速更快（2.0% vs -10.2%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-58.3M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -3.4%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Wheels Up是美国领先的按需私人航空服务提供商，也是全球规模最大的私人航空企业之一。公司由肯尼·迪希特创立于2013年，采用会员制按需服务的商业模式，会员可通过移动应用程序，从公司自有机队及第三方运营商处预订私人飞机出行。
OFIX vs UP — 直观对比
营收规模更大
OFIX
是对方的1.2倍
$183.8M
营收增速更快
OFIX
高出12.2%
-10.2%
净利率更高
OFIX
高出14.7%
-15.7%
自由现金流更多
OFIX
多$75.1M
$-58.3M
两年增速更快
OFIX
近两年复合增速
-3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $183.8M |
| 净利润 | $-2.2M | $-28.9M |
| 毛利率 | 71.1% | 14.3% |
| 营业利润率 | 0.2% | -0.9% |
| 净利率 | -1.0% | -15.7% |
| 营收同比 | 2.0% | -10.2% |
| 净利润同比 | 92.4% | 67.0% |
| 每股收益（稀释后） | $-0.05 | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXUP
| Q4 25 | $219.9M | $183.8M | ||
| Q3 25 | $205.6M | $185.5M | ||
| Q2 25 | $203.1M | $189.6M | ||
| Q1 25 | $193.6M | $177.5M | ||
| Q4 24 | $215.7M | $204.8M | ||
| Q3 24 | $196.6M | $193.9M | ||
| Q2 24 | $198.6M | $196.3M | ||
| Q1 24 | $188.6M | $197.1M |
净利润OFIXUP
| Q4 25 | $-2.2M | $-28.9M | ||
| Q3 25 | $-22.8M | $-83.7M | ||
| Q2 25 | $-14.1M | $-82.3M | ||
| Q1 25 | $-53.1M | $-99.3M | ||
| Q4 24 | $-29.1M | $-87.5M | ||
| Q3 24 | $-27.4M | $-57.7M | ||
| Q2 24 | $-33.4M | $-97.0M | ||
| Q1 24 | $-36.0M | $-97.4M |
毛利率OFIXUP
| Q4 25 | 71.1% | 14.3% | ||
| Q3 25 | 72.2% | 6.8% | ||
| Q2 25 | 68.7% | 8.3% | ||
| Q1 25 | 62.8% | 10.8% | ||
| Q4 24 | 69.0% | 13.9% | ||
| Q3 24 | 68.7% | 13.9% | ||
| Q2 24 | 67.8% | 2.3% | ||
| Q1 24 | 67.5% | -0.6% |
营业利润率OFIXUP
| Q4 25 | 0.2% | -0.9% | ||
| Q3 25 | -8.3% | -33.1% | ||
| Q2 25 | -7.9% | -31.4% | ||
| Q1 25 | -25.2% | -45.5% | ||
| Q4 24 | -5.3% | -26.0% | ||
| Q3 24 | -9.6% | -21.6% | ||
| Q2 24 | -12.5% | -40.3% | ||
| Q1 24 | -15.6% | -42.9% |
净利率OFIXUP
| Q4 25 | -1.0% | -15.7% | ||
| Q3 25 | -11.1% | -45.1% | ||
| Q2 25 | -6.9% | -43.4% | ||
| Q1 25 | -27.4% | -55.9% | ||
| Q4 24 | -13.5% | -42.7% | ||
| Q3 24 | -13.9% | -29.8% | ||
| Q2 24 | -16.8% | -49.4% | ||
| Q1 24 | -19.1% | -49.4% |
每股收益（稀释后）OFIXUP
| Q4 25 | $-0.05 | $-0.04 | ||
| Q3 25 | $-0.57 | $-0.12 | ||
| Q2 25 | $-0.36 | $-0.12 | ||
| Q1 25 | $-1.35 | $-0.14 | ||
| Q4 24 | $-0.76 | $-0.13 | ||
| Q3 24 | $-0.71 | $-0.08 | ||
| Q2 24 | $-0.88 | $-0.14 | ||
| Q1 24 | $-0.95 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $133.9M |
| 总债务越低越好 | — | $671.3M |
| 股东权益账面价值 | $450.0M | $-392.1M |
| 总资产 | $850.6M | $968.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXUP
| Q4 25 | $82.0M | $133.9M | ||
| Q3 25 | $62.9M | $125.3M | ||
| Q2 25 | $65.6M | $107.0M | ||
| Q1 25 | $58.0M | $171.8M | ||
| Q4 24 | $83.2M | $216.4M | ||
| Q3 24 | $30.1M | $115.9M | ||
| Q2 24 | $26.4M | $141.5M | ||
| Q1 24 | $27.0M | $180.9M |
总债务OFIXUP
| Q4 25 | — | $671.3M | ||
| Q3 25 | $157.2M | $766.5M | ||
| Q2 25 | $157.0M | $770.5M | ||
| Q1 25 | $156.9M | $765.8M | ||
| Q4 24 | $157.0M | $761.3M | ||
| Q3 24 | $118.5M | $596.9M | ||
| Q2 24 | $118.0M | $597.4M | ||
| Q1 24 | $118.2M | $603.2M |
股东权益OFIXUP
| Q4 25 | $450.0M | $-392.1M | ||
| Q3 25 | $442.5M | $-374.5M | ||
| Q2 25 | $458.3M | $-347.8M | ||
| Q1 25 | $458.3M | $-288.1M | ||
| Q4 24 | $503.1M | $-202.1M | ||
| Q3 24 | $525.9M | $-117.7M | ||
| Q2 24 | $546.0M | $-72.2M | ||
| Q1 24 | $570.3M | $936.0K |
总资产OFIXUP
| Q4 25 | $850.6M | $968.8M | ||
| Q3 25 | $832.6M | $973.0M | ||
| Q2 25 | $837.2M | $1.0B | ||
| Q1 25 | $823.1M | $1.1B | ||
| Q4 24 | $893.3M | $1.2B | ||
| Q3 24 | $867.9M | $1.0B | ||
| Q2 24 | $882.0M | $1.1B | ||
| Q1 24 | $906.0M | $1.2B |
负债/权益比OFIXUP
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | 644.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $-18.4M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $-58.3M |
| 自由现金流率自由现金流/营收 | 7.6% | -31.7% |
| 资本支出强度资本支出/营收 | 4.9% | 21.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $-259.9M |
8季度趋势，按日历期对齐
经营现金流OFIXUP
| Q4 25 | $27.7M | $-18.4M | ||
| Q3 25 | $12.4M | $-37.1M | ||
| Q2 25 | $11.6M | $-62.9M | ||
| Q1 25 | $-18.4M | $-47.9M | ||
| Q4 24 | $23.7M | $37.9M | ||
| Q3 24 | $11.7M | $-16.9M | ||
| Q2 24 | $9.0M | $-25.2M | ||
| Q1 24 | $-18.6M | $-73.8M |
自由现金流OFIXUP
| Q4 25 | $16.8M | $-58.3M | ||
| Q3 25 | $2.5M | $-60.4M | ||
| Q2 25 | $4.5M | $-78.6M | ||
| Q1 25 | $-25.1M | $-62.6M | ||
| Q4 24 | $15.2M | $-70.2M | ||
| Q3 24 | $6.3M | $-21.9M | ||
| Q2 24 | $-360.0K | $-30.8M | ||
| Q1 24 | $-29.1M | $-77.8M |
自由现金流率OFIXUP
| Q4 25 | 7.6% | -31.7% | ||
| Q3 25 | 1.2% | -32.6% | ||
| Q2 25 | 2.2% | -41.5% | ||
| Q1 25 | -13.0% | -35.3% | ||
| Q4 24 | 7.0% | -34.3% | ||
| Q3 24 | 3.2% | -11.3% | ||
| Q2 24 | -0.2% | -15.7% | ||
| Q1 24 | -15.4% | -39.5% |
资本支出强度OFIXUP
| Q4 25 | 4.9% | 21.7% | ||
| Q3 25 | 4.8% | 12.5% | ||
| Q2 25 | 3.5% | 8.3% | ||
| Q1 25 | 3.5% | 8.3% | ||
| Q4 24 | 4.0% | 52.8% | ||
| Q3 24 | 2.7% | 2.6% | ||
| Q2 24 | 4.7% | 2.9% | ||
| Q1 24 | 5.6% | 2.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
UP
暂无分部数据
